✦ LIBER ✦

PCN79 Cost Effectiveness of Erlotinib in First Line Treatment of Advanced Non Small Cell Lung Cancer (NSCLC) in Vulnerable Elderly Patients: An Economical Analysis of a prospective Phase 2 Study (GFPC 0505)

✍ Scribed by Chouaid, C.; Le Caer, H.; Corre, R.; Crequit, J.; Jullian, H.; Falchero, L.; Dujon, C.; Vergnenegre, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN84 COST-EFFECTIVENESS OF ERLOTINIB IN

✍ C Chouaid; H Lecaer; J Crequit; I Monnet; S Chouabe; C Locher; D Paillotin; JB A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Cost Analysis of Erlotinib Versus Chemot

✍ Chouaid, Christos; Le Caer, Hervé; Corre, Romain; Crequit, Jacquy; Locher, Chrys 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 781 KB

Cost effectivenes of erlotinib versus ch

✍ Chouaid Christos, Le Caer Hervé, Locher Chrystelle, Dujon Cecile, Thomas Pascal, 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 569 KB

PCN36 ECONOMIC EVALUATION OF ERLOTINIB,

✍ S Capri; A Morabito; G Carillio; F Grossi; R Longo; G Cerea; F Rossetti 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PCN81 COST-EFFECTIVENESS ANALYSIS OF THR

✍ I Borget; J Cadranel; A Mauguen; B Coudert; E Dansin; S Friard; C Daniel; E Quoi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Pemetrexed and carboplatin, an active op

✍ Gervais, Radj; Robinet, Gilles; Clément-Duchêne, Christelle; Denis, Fabrice; Kou 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 303 KB